My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 23

    1.

    Viewing metastatic colorectal cancer as a curable chronic disease.

    Chua TC, Liauw W, Chu F, Morris DL.

    Am J Clin Oncol. 2012 Feb;35(1):77-80.

    PMID:
    22257778
    [PubMed - indexed for MEDLINE]

    Related citations

    2.

    Patients with colorectal cancer are characterized by increased concentration of fecal hb-hp complex, myeloperoxidase, and secretory IgA.

    Chalkias A, Nikotian G, Koutsovasilis A, Bramis J, Manouras A, Mystrioti D, Katergiannakis V.

    Am J Clin Oncol. 2011 Dec;34(6):561-6. doi: 10.1097/COC.0b013e3181f9457e.

    PMID:
    21150566
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients.

    Lang AH, Geller-Rhomberg S, Winder T, Stark N, Gasser K, Hartmann B, Kohler B, Grizelj I, Drexel H, Muendlein A.

    BMC Cancer. 2012 Jan 17;12:20.

    PMID:
    22251819
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    4.

    Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC).

    Souglakos J, Ziras N, Kakolyris S, Boukovinas I, Kentepozidis N, Makrantonakis P, Xynogalos S, Christophyllakis Ch, Kouroussis Ch, Vamvakas L, Georgoulias V, Polyzos A.

    Br J Cancer. 2012 Jan 31;106(3):453-9. doi: 10.1038/bjc.2011.594. Epub 2012 Jan 12.

    PMID:
    22240792
    [PubMed - indexed for MEDLINE]

    Related citations

    5.

    Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer.

    Dotan E, Meropol NJ, Zhu F, Zambito F, Bove B, Cai KQ, Godwin AK, Golemis EA, Astsaturov I, Cohen SJ.

    Br J Cancer. 2012 Feb 14;106(4):748-55. doi: 10.1038/bjc.2011.587. Epub 2012 Jan 12.

    PMID:
    22240781
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    TGF-beta signalling in colon carcinogenesis.

    Lampropoulos P, Zizi-Sermpetzoglou A, Rizos S, Kostakis A, Nikiteas N, Papavassiliou AG.

    Cancer Lett. 2012 Jan 1;314(1):1-7. Epub 2011 Oct 7. Review.

    PMID:
    22018778
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    Aflibercept in the treatment of metastatic colorectal cancer.

    Wang TF, Lockhart AC.

    Clin Med Insights Oncol. 2012;6:19-30. Epub 2012 Jan 4.

    PMID:
    22253552
    [PubMed - in process]
    Free PMC Article

    Related citations

    8.

    A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer.

    Huidobro C, Urdinguio RG, Rodríguez RM, Mangas C, Calvanese V, Martínez-Camblor P, Ferrero C, Parra-Blanco A, Rodrigo L, Obaya AJ, Suárez-Fernández L, Astudillo A, Hernando H, Ballestar E, Fernández AF, Fraga MF.

    Eur J Cancer. 2012 Jan 13. [Epub ahead of print]

    PMID:
    22244828
    [PubMed - as supplied by publisher]

    Related citations

    9.

    Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells.

    Almeida MI, Nicoloso MS, Zeng L, Ivan C, Spizzo R, Gafà R, Xiao L, Zhang X, Vannini I, Fanini F, Fabbri M, Lanza G, Reis RM, Zweidler-McKay PA, Calin GA.

    Gastroenterology. 2012 Apr;142(4):886-896.e9. Epub 2012 Jan 10.

    PMID:
    22240480
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans.

    Chung SJ, Kim YS, Yang SY, Song JH, Kim D, Park MJ, Kim SG, Song IS, Kim JS.

    Gut. 2011 Nov;60(11):1537-43. Epub 2011 Mar 22.

    PMID:
    21427200
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Ascl2 and 11p15.5 amplification in colorectal cancer.

    Jubb AM, Hoeflich KP, Haverty PM, Wang J, Koeppen H.

    Gut. 2011 Nov;60(11):1606-7; author reply 1607. Epub 2010 Nov 23. No abstract available.

    PMID:
    21106550
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Aberrant protein expression and frequent allelic loss of MSH3 in colorectal cancer with low-level microsatellite instability.

    Plaschke J, Preußler M, Ziegler A, Schackert HK.

    Int J Colorectal Dis. 2012 Jan 10. [Epub ahead of print]

    PMID:
    22249440
    [PubMed - as supplied by publisher]

    Related citations

    13.

    Heterogeneity of colorectal cancers and extraction of discriminator gene signatures for personalized prediction of prognosis.

    Miyake M, Takemasa I, Matoba R, Tanino M, Niijima S, Ikeda M, Yamamoto H, Sekimoto M, Kuhara S, Okayama T, Monden M, Matsubara K, Mori M.

    Int J Oncol. 2011 Oct;39(4):781-9. doi: 10.3892/ijo.2011.1092. Epub 2011 Jun 22.

    PMID:
    21701771
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    Registries and randomized trials in assessing the effects of bevacizumab in colorectal cancer: is there a common theme?

    Hurwitz HI, Lyman GH.

    J Clin Oncol. 2012 Feb 20;30(6):580-1. Epub 2012 Jan 17. No abstract available.

    PMID:
    22253468
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer.

    Meyerhardt JA, Li L, Sanoff HK, Carpenter W 4th, Schrag D.

    J Clin Oncol. 2012 Feb 20;30(6):608-15. Epub 2012 Jan 17.

    PMID:
    22253466
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy.

    Govindarajan A, Gönen M, Weiser MR, Shia J, Temple LK, Guillem JG, Paty PB, Nash GM.

    J Clin Oncol. 2011 Dec 1;29(34):4568-73. Epub 2011 Oct 11.

    PMID:
    21990400
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience.

    Patel UB, Taylor F, Blomqvist L, George C, Evans H, Tekkis P, Quirke P, Sebag-Montefiore D, Moran B, Heald R, Guthrie A, Bees N, Swift I, Pennert K, Brown G.

    J Clin Oncol. 2011 Oct 1;29(28):3753-60. Epub 2011 Aug 29.

    PMID:
    21876084
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    Free peritoneal tumor cells detection in gastric and colorectal cancer patients.

    Rossi Del Monte S, Ranieri D, Mazzetta F, Kazemi Nava A, Raffa S, Torrisi MR, Ziparo V.

    J Surg Oncol. 2012 Jan 18. doi: 10.1002/jso.23052. [Epub ahead of print]

    PMID:
    22258756
    [PubMed - as supplied by publisher]

    Related citations

    19.

    Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer.

    Hyslop T, Weinberg DS, Schulz S, Barkun A, Waldman SA.

    J Surg Oncol. 2012 Jan 17. doi: 10.1002/jso.23051. [Epub ahead of print]

    PMID:
    22252429
    [PubMed - as supplied by publisher]

    Related citations

    20.

    Till death do us part.

    Rousseau P.

    Lancet Oncol. 2011 Dec;12(13):1192-3. No abstract available.

    PMID:
    22232804
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk